I'm LongbridgeAI, I can summarize articles.Upexi pre-market up 12.30%; DeFi Development pre-market up 10.49%; GlucoTrack pre-market up 80.10%; TNF Pharmaceuticals pre-market up 54.06%; Opendoor Tech pre-market up 34.22%
Pre-market Hot Trades in US Stocks
Upexi pre-market up 12.30%. Based on recent important news:
-
On July 18, Upexi announced it raised $100 million through a PIPE private placement, led by GSR, rapidly increasing its SOL assets, driving the stock price up 12.3%.
-
On July 18, Upexi CEO stated that they would continue to increase their holdings in SOL, with the stock price rising 254% since early July.
-
On July 18, Upexi completed a $150 million convertible bond issuance, holding 1.65 million SOL, with the stock price rising 20%.
DeFi Development pre-market up 10.49%. Based on recent important news:
- On July 18, DeFi Development announced the launch of the SOL Reserve Accelerator Program, gaining support from Kraken and others, driving international expansion and stimulating the stock price up 10.49%.
Top Gainers in Pre-market US Stocks
GlucoTrack pre-market up 80.10%. Based on recent important news:
-
On June 23, Baize Medical's dark pool closing price was 25.6% higher than the listing price, increasing market interest in medical stocks, driving GlucoTrack's stock price up.
-
On June 26, Saint Bella's dark pool closing price was 32% higher than the listing price, with the overall strong performance of the medical industry further boosting GlucoTrack's stock price.
-
On June 30, Tide Pharmaceuticals' dark pool closing price was 1.8% higher than the listing price, showing continued market attention on medical stocks, supporting GlucoTrack's upward trend.
TNF Pharmaceuticals pre-market up 54.06%. Based on recent important news:
-
On June 25, Rongchang Bio's core product Taitasip received patent term compensation, with the stock price soaring over 16%, reflecting market optimism about its future growth.
-
On June 26, Vor Bio performed poorly, laying off 95% of its staff, causing Rongchang Bio's stock price to plummet, indicating market concerns about its collaboration model.
-
On June 12, China National Pharmaceutical announced it would soon reach a significant licensing deal, with the stock price soaring nearly 18%, reflecting market confidence in its international strategy.
Opendoor Tech pre-market up 34.22%. Based on recent key news:
-
On July 18, Opendoor's stock price surged due to the meme stock craze and short squeeze, with a pre-market increase of 34.22%.
-
On July 18, over 60% of shares changed hands in the market, indicating strong investor interest and trading activity.
-
On July 18, analyst Eric Jackson stated that Opendoor could become a "100x stock," further stimulating market sentiment